Alkadi Tablet 1 Microgram (Alfacalcidol)

Adult dose

Chronic renal failure and osteoporosis: Administer alfacalcidol at 0.5 to 1 µg orally once daily. Hypoparathyroidism and other diseases due to vitamin D metabolism abnormalities: Administer this drug at 1 to 4 µg orally once daily.

Child dose

Osteoporosis: Administer alfacalcidol at 0.01 to 0.03 µg per kg of body weight orally once daily. Other conditions: Administer this drug at 0.05 to 0.1 µg per kg of body weight orally once daily.

This drug should not be taken by patients with high blood calcium levels (hypercalcemia), high phosphate levels (hyperphosphatemia), or high magnesium levels (hypermagnesemia). Patients whose serum calcium and phosphate product is above a certain level or those who have alkalosis (excessively alkaline blood) should also not take this drug. People exhibiting toxic symptoms from excessive vitamin D or those allergic to this drug or its components should refrain from using it. While taking this drug, do not concurrently use medications containing magnesium, vitamin D and its derivatives, calcium-containing medications, or certain diuretics. Moreover, if you are breastfeeding, it is recommended to avoid taking this drug, and if it must be taken, it is advisable to stop breastfeeding. Women who are pregnant or may become pregnant should definitely consult a doctor before taking this medication due to potential harm to the fetus. Children and the elderly may require dosage adjustments and should be monitored closely due to differing physiological functions. Since there may be interactions with specific medications while taking this drug, consult an expert if you are taking other medications. If symptoms such as indigestion, vomiting, muscle spasms, headache, dizziness, irregular heartbeat, or decreased kidney function occur during use, immediately discontinue the drug and consult with medical personnel. Regularly monitor serum calcium levels and kidney function, and if abnormalities are detected, appropriate action should be taken. This drug can exacerbate hypercalcemia or hyperphosphatemia; therefore, control the intake of calcium from meals or supplements and be aware of related symptoms. Avoid excessive doses while taking this drug; if overdose is suspected, seek immediate emergency care and manage serum calcium levels per medical advice. Keep this drug out of the reach of children, avoid direct sunlight, and store it in a cool, dry place. To maintain quality, do not transfer it to another container, and prevent misuse or abuse.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in oral/conjunctival mucosa, difficulty breathing or shortness of breath, asthma attacks, respiratory distress accompanied by cough and fever, yellowing of skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, changes in urine output

Mild side effects

• Loss of appetite
• nausea
• vomiting
• diarrhea
• constipation
• abdominal pain
• discomfort in the upper abdomen
• bloating
• dyspepsia
• thirst

This drug must be stored in a tightly sealed container to protect it from exposure to air and moisture. The storage temperature should be maintained between 1 degree and 30 degrees Celsius.

Appearance

White round tablets

Package unit

30 tablets/bottle, 100 tablets/bottle